# NVO

The FDA is taking action against companies like Hims & Hers for marketing unapproved GLP-1 drugs, a move seen as beneficial for Novo Nordisk. This regulatory scrutiny follows concerns raised by Novo Nordisk about the safety and efficacy of compounded versions of their popular weight-loss medications.

### About NVO
Novo Nordisk is a pharmaceutical company specializing in diabetes and obesity treatments.  

### Insights
- nvo sentiment is up 12.28% from the previous week.

### Engagements: [---------] (24h)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/t:nvo/c:line/m:interactions/iv:1d.svg)  
[Engagements 24-Hour Time-Series Raw Data](/topic/nvo/time-series/interactions.tsv)  
Current Value: [---------]  
Daily Average: [---------]  
[--] Week: [---] -99%  
[--] Month: [----------] -36%  
[--] Months: [-----------] +112%  
[--] Year: [-----------] +325%  
1-Year High: [---------] on 2025-11-24  
1-Year Low: [------] on 2025-03-09  

Engagements by network (24h):
Reddit: [-----]
TikTok: [------]
Instagram: [--]
News: [-----]
X: [---------]
YouTube: [-------]

  
  
### Mentions: [-----] (24h)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/t:nvo/c:line/m:posts_active/iv:1d.svg)  
[Mentions 24-Hour Time-Series Raw Data](/topic/nvo/time-series/posts_active.tsv)  
Current Value: [-----]  
Daily Average: [-----]  
1-Year High: [-----] on 2025-12-27  
1-Year Low: [---] on 2025-03-09  

Mentions by network (24h):
Reddit: [--]
TikTok: [--]
Instagram: [--]
News: [--]
X: [-----]
YouTube: [---]

  
  
### Creators: [-----] (24h)
![Creators Line Chart](https://lunarcrush.com/gi/w:600/t:nvo/c:line/m:contributors_active/iv:1d.svg)  
[Creators 24-Hour Time-Series Raw Data](/topic/nvo/time-series/contributors_active.tsv)  
[-----] unique social accounts have posts mentioning NVO in the last [--] hours which is up 67% from [---] in the previous [--] hours
Daily Average: [---]  
1-Year High: [-----] on 2025-12-24  
1-Year Low: [---] on 2025-03-09  

The most influential creators that mention NVO in the last [--] hours

| Creator                                          | Rank | Followers | Posts | Engagements |
| -------                                          | ---- | --------- | ----- | ----------- |
| [@Milapametnica](/creator/twitter/Milapametnica) | [--]    | [-----]     | [--]     | [--]          |

[View More](/list/creators/nvo/100)
  
  
### Sentiment: 68%
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:nvo/c:line/m:sentiment/iv:1d.svg)  
[Sentiment 24-Hour Time-Series Raw Data](/topic/nvo/time-series/sentiment.tsv)  
Current Value: 68%  
Daily Average: 73%  
[--] Week: 64% +7%  
[--] Month: 58% -23%  
[--] Months: 58% -22%  
[--] Year: 58% -17%  
1-Year High: 90% on 2025-04-24  
1-Year Low: 43% on 2025-05-31  

Most Supportive Themes:
- Diabetes Treatments: (60%) Novo Nordisk is a leading pharmaceutical company with a strong focus on developing and providing innovative treatments for diabetes.
- Obesity Solutions: (40%) The company is also at the forefront of research and development for effective solutions to combat obesity.
  
Most Critical Themes:
  

### Top NVO News
Top news links shared on social in the last [--] hours  

*Showing a maximum of [--] news posts without a LunarCrush subscription.*  

"Hims & Hers down as FDA to target copycat drugs (HIMS:NYSE) Seeking Alpha Hims & Hers (HIMS) stock drops as FDA warns against illegal copycat drugs while Novo (NVO) threatens action over the company"  
[News Link](https://seekingalpha.com/news/4548504-hims-hers-down-fda-target-copycat-drugs) [@SeekingAlpha](/creator/x/SeekingAlpha) 2026-02-06T18:00Z 318K followers, [----] engagements



### Top NVO Social Posts
Top posts by engagements in the last [--] hours

*Showing a maximum of [--] top social posts without a LunarCrush subscription.*

"Good point. Why arent more outraged at $NVO big pharma and the politicians in bed with big pharma instead of being upset at $HIMS Too much groupthink. Its like when more than half the country was upset with X for bringing back freedom of speech. Unbelievable. $HIMS My thoughts I have a small position in $HIMS I havent sold and dont intend to. I have been following the recent events with the GLP1 pill with interest and I simply dont understand the hate. Why are we not outraged at big pharmaceutical companies like $NVO I'm fed $HIMS My thoughts I have a small position in $HIMS I havent sold and"  
[X Link](https://x.com/nikoliasgoninus/status/2019982684597178391) [@nikoliasgoninus](/creator/x/nikoliasgoninus) 2026-02-07T03:52Z [----] followers, [----] engagements


"Hims Stock: EPIC DUMP in after hours after DOJ referral Time to Run Away What's Next. Join Patreon for Exclusive Perks: https://www.patreon.com/btdenominator #HIMS $HIMS In this no financial advice video I cover Hims stock and their incredible launch of the compounded oral semaglutide for $49 a month. Stunning the oral weight loss market And of course the stock is way down This is a fundamental deep dive Hims stock analysis. Today I specifically cover two threats. Is NVO going to fight back Is the FDA going to go after compounding What does the DOJ referral of Hims by Makary means for the"  
[YouTube Link](https://youtube.com/watch?v=i5hci3dS4Ro) [@beatthedenominator](/creator/youtube/beatthedenominator) 2026-02-07T03:31Z 23.3K followers, [----] engagements


"$VKTX $LLY $NVO $GPCR Yesterday obesity stocks saw big drop as $HIMS announced a low-cost compounded version of the Wegovy oral pill. Irrational fear overblown and now FDA taking action against non FDA approved GLP-1 drugs aka HIMS"  
[X Link](https://x.com/Pharmdca/status/2019957608137035856) [@Pharmdca](/creator/x/Pharmdca) 2026-02-07T02:13Z 108.6K followers, [----] engagements


""the market for compounded semaglutide in the united states is now roughly "equal" in size to novo nordisk's own glp-1 business" prev $NVO CEO if compounding is banned then this would be a major tailwind for $NVO $LLY"  
[X Link](https://x.com/SixSigmaCapital/status/2019945042983719125) [@SixSigmaCapital](/creator/x/SixSigmaCapital) 2026-02-07T01:23Z 32.7K followers, 15.3K engagements

Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing